Creative Planning boosted its holdings in Perrigo Company plc (NYSE:PRGO – Free Report) by 3.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,477 shares of the company’s stock after purchasing an additional 661 shares during the quarter. Creative Planning’s holdings in Perrigo were worth $485,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of PRGO. Sound Income Strategies LLC acquired a new position in shares of Perrigo during the 3rd quarter worth $9,846,000. CWM LLC lifted its holdings in Perrigo by 38.8% in the 3rd quarter. CWM LLC now owns 11,380 shares of the company’s stock valued at $298,000 after purchasing an additional 3,183 shares in the last quarter. O Keefe Stevens Advisory Inc. lifted its holdings in Perrigo by 36.8% in the 3rd quarter. O Keefe Stevens Advisory Inc. now owns 182,516 shares of the company’s stock valued at $4,787,000 after purchasing an additional 49,075 shares in the last quarter. Handelsbanken Fonder AB lifted its holdings in Perrigo by 26.7% in the 3rd quarter. Handelsbanken Fonder AB now owns 37,000 shares of the company’s stock valued at $971,000 after purchasing an additional 7,800 shares in the last quarter. Finally, Sanctuary Advisors LLC purchased a new position in Perrigo in the 2nd quarter valued at about $213,000. Hedge funds and other institutional investors own 95.91% of the company’s stock.
Perrigo Trading Up 7.9 %
PRGO stock opened at $27.34 on Thursday. The firm has a 50 day simple moving average of $26.26 and a 200-day simple moving average of $27.53. Perrigo Company plc has a twelve month low of $23.89 and a twelve month high of $34.60. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.99 and a quick ratio of 1.24.
Perrigo Announces Dividend
Insider Buying and Selling
In other Perrigo news, Director Katherine C. Doyle sold 8,954 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $27.30, for a total value of $244,444.20. Following the sale, the director now directly owns 6,009 shares in the company, valued at approximately $164,045.70. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, EVP Svend Andersen sold 28,300 shares of the company’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $27.75, for a total value of $785,325.00. Following the completion of the sale, the executive vice president now owns 73,553 shares of the company’s stock, valued at $2,041,095.75. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Katherine C. Doyle sold 8,954 shares of the company’s stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $27.30, for a total transaction of $244,444.20. Following the completion of the sale, the director now directly owns 6,009 shares of the company’s stock, valued at $164,045.70. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,254 shares of company stock worth $1,411,969 over the last ninety days. 0.40% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
PRGO has been the topic of several recent analyst reports. Jefferies Financial Group reiterated a “hold” rating and set a $30.00 price objective (down from $50.00) on shares of Perrigo in a report on Monday, September 23rd. StockNews.com downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Friday, October 25th. Piper Sandler dropped their target price on shares of Perrigo from $36.00 to $35.00 and set an “overweight” rating for the company in a research report on Thursday, July 11th. Finally, Canaccord Genuity Group reissued a “buy” rating and set a $42.00 target price on shares of Perrigo in a research report on Monday, September 30th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $37.00.
Read Our Latest Stock Analysis on PRGO
Perrigo Company Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Further Reading
- Five stocks we like better than Perrigo
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- What a Trump Win Looks Like for the Market Now and Into 2025
- The Risks of Owning Bonds
- Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
- Using the MarketBeat Stock Split Calculator
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.